Načítá se...
The role of the clinician in the multi-omics era: are you ready?
Since Garrod’s first description of alkaptonuria in 1902, and newborn screening for phenylketonuria introduced in the 1960s, P4 medicine (preventive, predictive, personalized, and participatory) has been a reality for the clinician serving patients with inherited metabolic diseases. The era of high-...
Uloženo v:
| Vydáno v: | J Inherit Metab Dis |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Springer Netherlands
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5959952/ https://ncbi.nlm.nih.gov/pubmed/29362952 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10545-017-0128-1 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|